(MENAFN- GetNews)


"The global wastewater surveillance market is undergoing significant changes driven by technological innovation, regulatory requirements, and increasing public health awareness."Browse 231 market data Tables and 55 Figures spread through 284 Pages and in-depth TOC on "Wastewater Surveillance Market by Product (Instruments & Equipment (Samplers, Ultracentrifuge, qPCR, Portable), Assays & Kits, Consumables), Application (Pathogen Detection, AMR Tracking), End User (Public Health, Govt, Hospitals) - Global Forecast to 2030

The report "Wastewater Surveillance Market by Product (Instruments & Equipment (Samplers, Ultracentrifuge, qPCR, Portable), Assays & Kits, Consumables), Application (Pathogen Detection, AMR Tracking), End User (Public Health, Govt, Hospitals) - Global Forecast to 2030", is projected to reach USD 1.22 billion by 2030 from an estimated USD 0.88 billion in 2025, at a CAGR of 6.7% during the forecasted period. The growth of the wastewater surveillance market is fueled by increased awareness of infectious disease outbreaks, antimicrobial resistance (AMR), heightened public health monitoring efforts, and advancements in molecular testing. Governments and health organizations worldwide are progressively investing in wastewater-based epidemiology (WBE) as a cost-effective, non-invasive method for early detection of emerging pathogens and community health trends.

Wastewater surveillance is gaining momentum as a public health tool after COVID-19 and is expanding beyond just viral detection to include antimicrobial resistance monitoring, drug residue detection, and environmental health assessment. Technologies such as qPCR, next-generation sequencing (NGS), biosensors, and digital health platforms enable real-time data collection and analysis for decision-making.

Market players are implementing advanced sampling systems, automated testing solutions, and cloud-based data platforms to improve the speed, scalability, and accuracy of surveillance programs. Collaborations among public health agencies, academic institutions, and wastewater utilities are further speeding up market growth penetration.

However, key challenges in the market include maintaining sample quality and representativeness, standardizing testing protocols, managing data privacy, and addressing funding and regulatory hurdles, especially in low- and middle-income countries.

Download PDF Brochure

The instruments segment dominated the product type market in 2024.

In 2024, the instruments & equipment segment accounted for the largest share of the wastewater surveillance product type market. This segment includes core technologies such as automated wastewater samplers, PCR and qPCR instruments, ultracentrifugation equipment, and NGS sequencers. These components form the backbone of wastewater monitoring infrastructure, enabling sample collection, pathogen concentration, and molecular detection. The increasing deployment of surveillance programs across municipalities and institutions is driving demand for robust and scalable instrumentation. PCR and qPCR instruments remain particularly dominant due to their established use in viral load quantification, especially during the COVID-19 pandemic. Automated sampling systems further improve efficiency, reduce manual intervention, and enhance data consistency. Continued investment in infrastructure, modernization, and public health preparedness across regions ensures that this segment will maintain its leadership throughout the forecast period.

The detection assays & testing kits segment recorded the fastest growth rate during the forecast period.

The detection assays & testing kits segment is expected to experience the fastest growth from 2025 to 2030, driven by increasing demand for targeted and multiplex pathogen detection in wastewater. This segment includes viral and bacterial detection kits, AMR gene panels, and pharmaceutical residue testing solutions. As wastewater surveillance expands beyond COVID-19 to monitor pathogens like influenza, norovirus, Salmonella, and emerging AMR threats, laboratories are shifting toward sensitive, rapid-turnaround assays. Additionally, rising investments in public health infrastructure and epidemiological intelligence are accelerating the procurement of ready-to-use kits to improve throughput. The demand is especially strong in academic labs, contract testing organizations, and local health departments that require scalable, validated detection tools. Technological advancements in multiplex PCR and NGS-compatible kits are further driving segment growth by enabling broader surveillance with fewer resources.

The US is expected to hold the largest share of the North American market during the forecast period.

The US holds the largest share of the North American wastewater surveillance market mainly because of strong public health infrastructure, early adoption of wastewater epidemiology, and solid government funding. The CDC's National Wastewater Surveillance System (NWSS), launched in 2020, has played a key role in increasing national capacity and standardizing procedures. More than 1,200 sampling sites across states are already active, with plans to expand. Additionally, collaboration among public health agencies, academic institutions, and private labs has encouraged innovation in sampling, testing, and data analysis. The U.S. also benefits from major companies in instrumentation, assay kits, and analytics software, which reinforces its leading position. State investments, especially in California, New York, and Massachusetts, continue to fuel market growth. High awareness, policy support, and readiness for outbreak response make the U.S. the dominant player in the region.

As of 2024, key players in the Wastewater Surveillance market are Biobot Analytics (US), Verily Life Sciences (US), Eurofins Scientific (Luxembourg), GT Molecular (US), LuminUltra Technologies (Canada), Kando (Israel), Bio-Rad Laboratories (US), IDEXX Laboratories (US), Hach (US), Thermo Fisher Scientific (US), Qiagen (Germany), Randox Laboratories (UK), 4sensing (Germany), Teledyne ISCO (US), and Digital Proteomics (India).

Request for sample Report

MENAFN10112025003238003268ID1110323710